Castro-Diaz, D., Miranda, P., Sanchez-Ballester, F., Lizarraga, I., Arumí, D., & Rejas, J. (2012). Dose and aging effect on patients reported treatment benefit switching from the first overactive bladder therapy with tolterodine ER to fesoterodine: Post-hoc analysis from an observational and retrospective study. BioMed Central.
シカゴスタイル引用形Castro-Diaz, David, Pilar Miranda, Francisco Sanchez-Ballester, Isabel Lizarraga, Daniel Arumí, , Javier Rejas. Dose and Aging Effect On Patients Reported Treatment Benefit Switching From the First Overactive Bladder Therapy With Tolterodine ER to Fesoterodine: Post-hoc Analysis From an Observational and Retrospective Study. BioMed Central, 2012.
MLA引用形式Castro-Diaz, David, et al. Dose and Aging Effect On Patients Reported Treatment Benefit Switching From the First Overactive Bladder Therapy With Tolterodine ER to Fesoterodine: Post-hoc Analysis From an Observational and Retrospective Study. BioMed Central, 2012.